PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Cost analysis
• Cost analysis of valve replacement procedures
PART 07: Market segmentation by product
• Global mechanical heart valves market
• Global tissue heart valves market
• Global transcatheter heart valves market
PART 08: Geographical segmentation
• Heart valves market in Americas
• Heart valves market in EMEA
• Heart valves market in APAC
PART 09: Market drivers
• Incidence of heart valve diseases
• Implementation of minimally invasive procedures
• Use of transcatheter valve replacement technology
• Rise in older population
PART 10: Impact of drivers
PART 11: Market challenges
• Risk of potential complications
• Lack of skilled personnel
• Expensive heart valve replacement procedures
• Stringent regulatory framework
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Focus on US
• Increase in M&A
• Use of stentless tissue valves
• Development of novel heart valves
PART 14: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Key vendors
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
PART 16: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global heart valves market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
Exhibit 05: Global heart valves market segmentation by product
Exhibit 06: Global heart valves market segmentation by product 2015
Exhibit 07: Global heart valves market segmentation by product 2020
Exhibit 08: Global heart valves market segmentation by product 2015-2020
Exhibit 09: Global mechanical heart valves market segmentation by type
Exhibit 10: Characteristics of mechanical valves
Exhibit 11: Global mechanical heart valves market 2015-2020 ($ millions)
Exhibit 12: Global tissue heart valves market segmentation by type 2015
Exhibit 13: Global tissue heart valves market 2015-2020 ($ billion)
Exhibit 14: Global transcatheter heart valves market by type 2015
Exhibit 15: Global transcatheter heart valves market 2015-2020 ($ billions)
Exhibit 16: Global heart valves market segmentation by geography 2015
Exhibit 17: Global heart valves market segmentation by geography 2020
Exhibit 18: Global heart valves market segmentation by geography 2015-2020
Exhibit 19: Heart valves market in Americas 2015-2020 ($ billions)
Exhibit 20: Heart valves market in EMEA 2015-2020 ($ billions)
Exhibit 21: Heart valves market in APAC 2015-2020 ($ billions)
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Major acquisitions 2015
Exhibit 25: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 26: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 27: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 28: Edwards Lifesciences: Business segmentation by revenue 2015
Exhibit 29: Edwards Lifesciences: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 30: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment 2013-2015 ($ millions)
Exhibit 31: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in US 2013-2015 ($ millions)
Exhibit 32: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in ROW 2013-2015 ($ millions)
Exhibit 33: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment 2013-2015 ($ millions)
Exhibit 34: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in US 2013-2015 ($ millions)
Exhibit 35: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in ROW 2013-2015 ($ millions)
Exhibit 36: Edwards Lifesciences: Key takeaways
Exhibit 37: LivaNova: Revenue of cardiac surgery segment by geography 2015
Exhibit 38: LivoNova: Key takeaways
Exhibit 39: Medtronic: Product portfolio
Exhibit 40: Medtronic: Product segmentation by revenue 2015
Exhibit 41: Medtronic: Key takeaways
Exhibit 42: St. Jude Medical: Product portfolio
Exhibit 43: St. Jude Medical: Revenue and YoY growth of structural heart segment 2013-2015 ($ millions)
Exhibit 44: St. Jude Medical: Key takeaways
Exhibit 45: Other prominent vendors
【掲載企業】
Edwards Lifesciences, LivaNova, Medtronic, St. Jude Medical, Abbott Laboratories, Braile Biomedica, Cardious, Colibri Heart Valve, corlife OHG, JenaValve Technology, Lepu Medical Technology (Beijing), Meril Life Sciences, Neovasc, ON-X Life Technologies, Pulmonx, Roskardioinvest, SYMETIS.
【資料のキーワード】
心臓弁、機械式心臓弁、組織心臓弁、経カテーテル心臓弁
【調査方法】
一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)